<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41310-bib-0016">
 <label>16</label>
 <mixed-citation publication-type="miscellaneous" id="hep41310-cit-0016">
  <string-name>
   <surname>Chen</surname>
   <given-names>C</given-names>
  </string-name>. Gileadâ€™s new hepatitis C drug approved by FDA, priced at $74,760. 
  <ext-link ext-link-type="uri" xlink:href="https://www.bloomberg.com/news/articles/2016-06-28/gilead-wins-fda-approval-of-hepatitis-c-drug-for-all-genotypes" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.bloomberg.com/news/articles/2016-06-28/gilead-wins-fda-approval-of-hepatitis-c-drug-for-all-genotypes</ext-link>. Published June 28, 2016. Accessed October 2, 2017.
 </mixed-citation>
</ref>
